article · International Journal of Community Medicine and Public Health
Background: Urinary schistosomiasis caused by Schistosoma haematobium, remains a significant health challenge in sub-Saharan Africa particularly Nigeria. The study investigated the prevalence of the infection among school-age children in Ohaukwu Local Government Area of Ebonyi State, Nigeria. Methods: A total of 570 pupils (308 males, 262 females) from 10 primary schools were examined using microscopy technique. A well-structured questionnaire was administered to collect demographic information, asses the level of knowledge and risk factors of schistosomiasis among the pupils. Results: The overall prevalence was 15.1% (86/570), with males more infected (17.9%) than females (11.8%). The difference was statistically significant (p<0.05). Children in the age 11-15 had the highest infection rate 20.5% (62/302) than other age groups. Chi-square test showed that the differences in prevalence among the age groups were statistically significant (p=0.001). Among the component schools, infection was highest in State Primary School Ekwashi Ngbo 36.7% (18/49). The overall mean intensity was 11.35 eggs/10 ml of urine with females having a higher mean intensity (13.26 egg/10 ml of urine) than males (10.27 eggs/10 ml of urine). Most pupils (89.5%) had light infection. Pupils of age group 6-10 years mean egg intensity (17.72 eggs/10 ml of urine) was highest. Mean intensity of S. haematobium infection was found to decrease with advancement in age. Knowledge of the infection was poor, with 95.79% of participants having no knowledge. Conclusions: Extensive campaign on the awareness of the disease and scale-up of mass drug administration of praziquantel to help in the control of the disease is highly recommended.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.18203/2394-6040.ijcmph20253669
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.